Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tommaso Ruelle"'
Autor:
Irene Giannubilo, Linda Battistuzzi, Eva Blondeaux, Tommaso Ruelle, Francesca Benedetta Poggio, Giulia Buzzatti, Alessia D’Alonzo, Federica Della Rovere, Maria Maddalena Latocca, Chiara Molinelli, Maria Grazia Razeti, Simone Nardin, Luca Arecco, Marta Perachino, Diletta Favero, Roberto Borea, Paolo Pronzato, Lucia Del Mastro, Claudia Bighin
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Objectives To better understand the type of care offered to Italian patients with advanced breast cancer at the End-of-Life (EoL), we conducted a retrospective observational study. EoL was defined as the period of six months before death. Me
Externí odkaz:
https://doaj.org/article/1811377c3ab741bd86758ad1997e27b8
Autor:
Caterina Caminiti, Giuseppe Maglietta, Laura Arenare, Raimondo Di Liello, Gessica Migliaccio, Daniela Barberio, Michelino De Laurentiis, Francesca Di Rella, Francesco Nuzzo, Carmen Pacilio, Giovanni Iodice, Michele Orditura, Fortunato Ciardiello, Sara Di Bella, Luigi Cavanna, Camillo Porta, Filippo Giovanardi, Carla Ida Ripamonti, Domenico Bilancia, Giuseppe Aprile, Tommaso Ruelle, Francesca Diodati, Maria Carmela Piccirillo, Elisabetta Iannelli, Carmine Pinto, Francesco Perrone
Publikováno v:
Breast, Vol 77, Iss , Pp 103781- (2024)
Patients’ self-reporting is increasingly considered essential to measure quality-of-life and treatment-related side-effects. However, if multiple patient-reported instruments are used, redundancy may represent an overload for patients.Patient-Repor
Externí odkaz:
https://doaj.org/article/71e5c3ed11094be79d7a7512d079914a
Autor:
Massimo Di Maio, Claudia Bighin, Francesco Schettini, Tommaso Ruelle, Laura Marandino, Alessandra Fabi, Carmine De Angelis, Mario Giuliano, Pietro De Placido, Michelino De Laurentiis, Ferdinando Riccardi, Caterina Picotto, Fabio Puglisi, Lucia Del Mastro, Grazia Arpino
Publikováno v:
Breast, Vol 72, Iss , Pp 103583- (2023)
Background: Treatment for HER2-positive (+) metastatic breast cancer has improved in the last decade. We analyzed treatment changes over time and their impact on patients outcomes in a real-world dataset. Methods: Data from 637 HER2+ patients with me
Externí odkaz:
https://doaj.org/article/4d2b4ec77a90481d9884d1101fc4625e
Autor:
Eva Blondeaux, Claudia Massarotti, Valeria Fontana, Francesca Poggio, Luca Arecco, Piero Fregatti, Claudia Bighin, Irene Giannubilo, Tommaso Ruelle, Maria Grazia Razeti, Luca Boni, Paola Anserini, Lucia Del Mastro, Matteo Lambertini
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundOffering ovarian function and/or fertility preservation strategies in premenopausal women with newly diagnosed breast cancer candidates to undergo chemotherapy is standard of care. However, few data are available on uptake and main reasons
Externí odkaz:
https://doaj.org/article/27bd11f112ed4628ac7f516f104e8355
Autor:
Lucia Del Mastro, Marco Tagliamento, M.A. Franzoi, Piero Fregatti, Maria Grazia Razeti, Marcello Ceppi, Matteo Lambertini, Tommaso Ruelle, Marco Bruzzone, Paolo Pronzato, Claudia Massarotti, Francesca Poggio
Publikováno v:
Breast Cancer Research and Treatment. 191:269-275
Symptoms of treatment-induced menopause negatively affect quality of life and adherence to endocrine therapy of breast cancer (BC) survivors. Nevertheless, the use of systemic hormone replacement therapy (HRT) to mitigate these symptoms may be associ
Autor:
Marta Perachino, Maria Maddalena Latocca, Maurizio Cosso, Piero Fregatti, Marco Tagliamento, Matteo Lambertini, Valentino Martelli, Maria Grazia Razeti, Kristi Beshiri, Luca Arecco, Tommaso Ruelle
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 13, Pp 341-351 (2021)
Breast Cancer : Targets and Therapy
Breast Cancer : Targets and Therapy
Valentino Martelli,1,2 Maria Maddalena Latocca,1,2 Tommaso Ruelle,1,2 Marta Perachino,1,2 Luca Arecco,1,2 Kristi Beshiri,1,2 Maria Grazia Razeti,1,2 Marco Tagliamento,1,2 Maurizio Cosso,3 Piero Fregatti,4,5 Matteo Lambertini1,2 1Department of Medical
Autor:
Fregatti, Giulia Atzori, Marco Gipponi, Chiara Cornacchia, Raquel Diaz, Marco Sparavigna, Maurizio Gallo, Tommaso Ruelle, Federica Murelli, Simonetta Franchelli, Francesca Depaoli, Daniele Friedman, Piero
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 7; Pages: 1031
Background/Aim: Patients with Stage I-II breast cancer undergoing breast-conserving surgery after neoadjuvant chemotherapy (BCS-NAC) were retrospectively assessed in order to evaluate the extent of a safe excision margin. Materials and Methods: Betwe
Autor:
Giulia Atzori, Marco Gipponi, Chiara Cornacchia, Raquel Diaz, Marco Sparavigna, Maurizio Gallo, Tommaso Ruelle, Federica Murelli, Simonetta Franchelli, Francesca Depaoli, Daniele Friedman, Piero Fregatti
Publikováno v:
Journal of Personalized Medicine. 12:1031
Background/Aim: Patients with Stage I-II breast cancer undergoing breast-conserving surgery after neoadjuvant chemotherapy (BCS-NAC) were retrospectively assessed in order to evaluate the extent of a safe excision margin. Materials and Methods: Betwe
Autor:
P. Pugliese, G. Targato, A. Fabi, Alessia D'Alonzo, L. Del Mastro, C. Mulinelli, Michela Piezzo, I. Giannubilo, Matteo Lambertini, L. Cerbone, Marta Bonotto, M. De Laurentiis, Luca Boni, Stefania Russo, Claudia Bighin, Eva Blondeaux, Grazia Arpino, Benedetta Conte, Tommaso Ruelle
Publikováno v:
Annals of Oncology. 32:S475-S476
Autor:
Giulia Buzzatti, A. Ferzi, Claudia Bighin, L. Del Mastro, Eva Blondeaux, M. De Laurentiis, Alessia D'Alonzo, Tommaso Ruelle, A. Fabi, P. Pugliese, Francesca Poggio, Luca Boni, Grazia Arpino, B. Fratini, V. Di Lauro, Simona Gasparro, Ornella Garrone, Stefania Russo, Michela Piezzo, Chiara Molinelli
Publikováno v:
Annals of Oncology. 32:S497-S498